UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

3085 - Generation of a Novel Mouse Model Recapitulating Features of Human Acute Megakaryoblastic Leukemia

Experimental hematology, 2018-08, Vol.64, p.S79-S79

2018

Volltextzugriff (PDF)

3124 - Identification of Novel Therapeutic Targets in Acute Megakaryoblastic Leukemia

Experimental hematology, 2018-08, Vol.64, p.S89-S90

2018

Volltextzugriff (PDF)

3168 – INVESTIGATING THE ROLE OF THE KDM4A LYSINE DEMETHYLASE IN PEDIATRIC ACUTE MYELOID LEUKEMIA

Experimental hematology, 2019-08, Vol.76, p.e2-e3

2019

Volltextzugriff (PDF)

A54: Insulin Sensitivity Is Improved in sJIA Children With Insulin Resistance After Tocilizumab Treatment: Results From the TENDER Study

Arthritis & rheumatology (Hoboken, N.J.), 2014-03, Vol.66 (S3), p.S80-S81

2014

Volltextzugriff (PDF)

ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia

Nature communications, 2023-09, Vol.14 (1), p.5709-16, Article 5709

2023

Volltextzugriff (PDF)

Abstract 1459: A mechanism counteracting micronucleation for maintenance of genomic integrity

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1459-1459

2018

Volltextzugriff (PDF)

Abstract 2067: QUANTROseq, a transcriptomic based drug discovery platform using time-resolved gene expression profiling: Identification of inhibitors and degraders of transcription factors and cell signaling regulators

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2067-2067

2024

Volltextzugriff (PDF)

Abstract 2935: RNAi screen identifies therapeutic targets in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2935-2935

2014

Volltextzugriff (PDF)

Abstract 2974: RNAi mouse models: Revolutionizing drug discovery in vivo

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2974-2974

2014

Volltextzugriff (PDF)

Abstract 3452: The cohesin subunit STAG1 is a hardwired genetic dependency of STAG2 mutant cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3452-3452

2017

Volltextzugriff (PDF)

Abstract 3973: Precision RNAi using synthetic shRNAmir target sites

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3973-3973

2023

Volltextzugriff (PDF)

Abstract 4188: RNAi and CRISPR/Cas9 based in vivo models for drug discovery

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4188-4188

2016

Volltextzugriff (PDF)

Abstract 4188: RNAi and CRISPRCas9 based in vivo models for drug discovery

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4188-4188

2016

Volltextzugriff (PDF)

Abstract 4273: An enhanced microRNA backbone for potent single-copy RNAi

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4273-4273

2014

Volltextzugriff (PDF)

Abstract 5106: CRISPR/Cas9-based development of RNAi rat models for drug discovery

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5106-5106

2018

Volltextzugriff (PDF)

Abstract 5533: RNAi-mediated depletion of histone deacetylases highlights the potential for isoform-specific inhibitors in B-cell lymphoma and acute myeloid leukemia

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5533-5533

2014

Volltextzugriff (PDF)

Abstract 6119: RNAi rat models for drug discovery

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6119-6119

2020

Volltextzugriff (PDF)

Abstract 6221: Targeting IAP in cancer: BI 891065 a potent small molecule SMAC mimetic that synergizes with immune checkpoint inhibition

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6221-6221

2020

Volltextzugriff (PDF)

Abstract A20: Depletion of replication factor MCM7 is synthetically lethal to oncogenic KRAS expression

Molecular cancer therapeutics, 2017-10, Vol.16 (10_Supplement), p.A20-A20

2017

Volltextzugriff (PDF)

Abstract B16: Inhibition of RNA Polymerase I transcription by CX-5461 as a therapeutic strategy for the cancer-specific activation of p53 in highly refractory haematological malignancies

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (19_Supplement), p.B16-B16

2013

Volltextzugriff (PDF)

Abstract B37: RNAi and CRISPR/Cas9-based in vivo models for drug discovery

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10_Supplement), p.B37-B37

2018

Volltextzugriff (PDF)

Abstract PO-132: CaTCH - A barcode-guided CRISPRa-inducible reporter to isolate clones from heterogeneous populations

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21_Supplement), p.PO-132-PO-132

2020

Volltextzugriff (PDF)

Abstract PR07: RNAi mouse models: Revolutionizing drug discovery in vivo

Molecular cancer research, 2014-11, Vol.12 (11_Supplement), p.PR07-PR07

2014

Volltextzugriff (PDF)

Agent-based simulations for protecting nursing homes with prevention and vaccination strategies

Journal of the Royal Society interface, 2021-12, Vol.18 (185), p.20210608

2021

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Aktive Filter

ThemaBiochemistry & Molecular Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Englisch
(232)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(107)
Humans
(93)
Animals
(78)
Mice
(71)
Cell Biology
(39)
Cell Line, Tumor
(37)
Female
(28)
Mice, Inbred C57bl
(27)
Multidisciplinary Sciences
(27)
Oncology
(27)
Science & Technology - Other Topics
(27)
Leukemia
(26)
Genetics & Heredity
(22)
Hematology
(22)
Humanities And Social Sciences
(22)
Multidisciplinary
(21)
Rna Interference
(21)
Science
(21)
Cancer
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

3085 - Generation of a Novel Mouse Model Recapitulating Features of Human Acute Megakaryoblastic Leukemia

3124 - Identification of Novel Therapeutic Targets in Acute Megakaryoblastic Leukemia

3168 – INVESTIGATING THE ROLE OF THE KDM4A LYSINE DEMETHYLASE IN PEDIATRIC ACUTE MYELOID LEUKEMIA

A54: Insulin Sensitivity Is Improved in sJIA Children With Insulin Resistance After Tocilizumab Treatment: Results From the TENDER Study

ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia

Abstract 1459: A mechanism counteracting micronucleation for maintenance of genomic integrity

Abstract 2067: QUANTROseq, a transcriptomic based drug discovery platform using time-resolved gene expression profiling: Identification of inhibitors and degraders of transcription factors and cell signaling regulators

Abstract 2935: RNAi screen identifies therapeutic targets in hepatocellular carcinoma

Abstract 2974: RNAi mouse models: Revolutionizing drug discovery in vivo

Abstract 3452: The cohesin subunit STAG1 is a hardwired genetic dependency of STAG2 mutant cancer cells

Abstract 3973: Precision RNAi using synthetic shRNAmir target sites

Abstract 4188: RNAi and CRISPR/Cas9 based in vivo models for drug discovery

Abstract 4188: RNAi and CRISPRCas9 based in vivo models for drug discovery

Abstract 4273: An enhanced microRNA backbone for potent single-copy RNAi

Abstract 5106: CRISPR/Cas9-based development of RNAi rat models for drug discovery

Abstract 5533: RNAi-mediated depletion of histone deacetylases highlights the potential for isoform-specific inhibitors in B-cell lymphoma and acute myeloid leukemia

Abstract 6119: RNAi rat models for drug discovery

Abstract 6221: Targeting IAP in cancer: BI 891065 a potent small molecule SMAC mimetic that synergizes with immune checkpoint inhibition

Abstract A20: Depletion of replication factor MCM7 is synthetically lethal to oncogenic KRAS expression

Abstract B16: Inhibition of RNA Polymerase I transcription by CX-5461 as a therapeutic strategy for the cancer-specific activation of p53 in highly refractory haematological malignancies

Abstract B37: RNAi and CRISPR/Cas9-based in vivo models for drug discovery

Abstract PO-132: CaTCH - A barcode-guided CRISPRa-inducible reporter to isolate clones from heterogeneous populations

Abstract PR07: RNAi mouse models: Revolutionizing drug discovery in vivo

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Agent-based simulations for protecting nursing homes with prevention and vaccination strategies

Aktive Filter

Suchergebnisse filtern